Cart
0

Intraocular Lens Market by Type [Monofocal Intraocular Lens and Premium Intraocular Lens (Toric Intraocular Lens, Multifocal Intraocular Lens, and Accommodating Intraocular Lens)], Material [Polymethylmethacrylate (PMMA), Silicone and Hydrophobic Acrylic], and End User (Hospitals, Ambulatory Surgical Centers, Ophthalmology Clinics, and Eye Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Get 20% Free Customization In This Report
LI_172092
Pages: 131
Apr 2017 | 5097 Views
 
Author's : Deepa Tatkare
Tables: 65
Charts: 81
 

Intraocular Lens Market Overview

Global Intraocular Lens Market was valued at $3,306 million in 2015 and is expected to garner $4,973 million by 2022, registering a CAGR of 5.9% during the forecast period. Intraocular lens is an artificial lens, which is implanted in the eye to replace the natural lens during cataract surgery. Growth in geriatric population susceptible to ocular conditions, rise in prevalence of cataract, and increase in initiatives taken by government to eliminate avoidable blindness are expected to drive the growth of the global intraocular lens market. Moreover, rise in adoption of premium lens owing to its benefits such as enhanced visual performance and reduced astigmatism supplements the growth of the market. However, unfavorable reimbursement scenario for premium lens and postoperative complications such as refractive errors are expected to impede the market growth.

Get more information on this report : Request Sample Pages

According to the World Health Organization, cataract is a major concern globally, which is currently the leading cause of blindness. Increase in prevalence of cataract has increased the demand for intraocular lens globally. As per the Vision Council, around 76.2% adults in the U.S. underwent vision correction surgery in 2015, and approximately 22.1% of the adults expressed that they need vision correction. These factors contribute to the growth of the market.

Government initiatives and awareness programs to eliminate avoidable blindness are together expected to propel the demand for intraocular lens in the Asia-Pacific region. For instance, in 2011, Lions Clubs International Foundation (LCIF) in partnership with Peoples Republic of China initiated a new phase of their campaign in China known as SightFirst China Action (SFCA), which aims at preventing blindness. Since its formation in 1997, the foundation invested more than $30.8 million for more than 5 million cataract surgeries and upgradation of 300 eye care institutions and above. In addition, the Chinese government funded more than $200 million to support their campaign.

Intraocular lenses were first approved by FDA in 1980s, and since then, these lenses are in cataract surgery. Now-a-days, a wide variety of lenses are available; among these, the most commonly used are pseudophakic intraocular lens, which are implanted when a person undergoes cataract surgery.

The key companies operating in the intraocular lens market are Alcon, Inc. (division of Novartis AG), Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, and HOYA GROUP. The other players operating in the market include PhysIOL s.a., Calhoun Vision Center, and Oculentis GmBH.

Intraocular Lens Market Key Benefits:

  • The study provides an in-depth analysis of the global intraocular lens market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Quantitative analysis from 2014 to 2022 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • The report provides data for 2014 and year-on-year forecasts from 2016 to 2022.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Intraocular Lens Market Key Segments:

By Type

  • Monofocal Intraocular Lens
  • Premium Intraocular Lens
    • Toric Intraocular Lens
    • Multifocal Intraocular Lens
    • Accommodating Intraocular Lens
    • Others
      • Blue Light Filtering Intraocular Lens
      • Phakic Intraocular Lens
      • Aspheric Intraocular Lens

By Material

  • Polymethylmethacrylate (PMMA)
  • Silicone
  • Hydrophobic Acrylic

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Ophthalmology Clinics
  • Eye Research Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Netherlands
    • Norway
    • Russia
    • Sweden
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • New Zealand
    • Taiwan
    • Thailand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Chile
    • Columbia
    • Egypt
    • Iran
    • Israel
    • Turkey
  • Venezuela
  • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies

3.2.1.1. Competitive intelligence and strategies of companies

3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Increase in prevalence of cataract
3.4.1.2. Rise in adoption of premium intraocular lens
3.4.1.3. Increasing government initiatives
3.4.1.4. Increase in pool of geriatric population susceptible to ocular conditions
3.4.1.5. Growth in number of diabetic patients

3.4.2. Restraints

3.4.2.1. Post-operative complications
3.4.2.2. Lack of coverage of premium lens

3.4.3. Opportunities

3.4.3.1. Availability of advanced technologies
3.4.3.2. Emerging nations

3.4.4. Impact analysis

3.5. PORTERS FIVE FORCES ANALYSIS

3.5.1. Bargaining power of buyers
3.5.2. Bargaining power of suppliers
3.5.3. Threat of substitutes
3.5.4. Threat of new entrants
3.5.5. Competitive rivalry

3.6. GOVERNMENT REGULATIONS
3.7. CLINICAL TRIALS

Chapter: 4 INTRAOCULAR LENS MARKET,  BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. MONOFOCAL INTRAOCULAR LENS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. PREMIUM INTRAOCULAR LENS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Toric intraocular lens
4.3.3.2. Market size and forecast
4.3.3.3. Multifocal intraocular lens
4.3.3.4. Market size and forecast
4.3.3.5. Accommodating intraocular lens
4.3.3.6. Market size and forecast
4.3.3.7. Other intraocular lenses
4.3.3.8. Market size and forecast

4.3.3.8.1. Blue light filtering intraocular lens
4.3.3.8.2. Market size and forecast
4.3.3.8.3. Phakic intraocular lens
4.3.3.8.4. Market size and forecast
4.3.3.8.5. Aspheric intraocular lens
4.3.3.8.6. Market size and forecast

Chapter: 5 INTRAOCULAR LENS MARKET,  BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. AMBULATORY SURGICAL CENTERS (ASCS)

5.3.1. Market size and forecast

5.4. OPHTHALMOLOGY CLINICS

5.4.1. Market size and forecast

5.5. EYE RESEARCH INSTITUTES

5.5.1. Market size and forecast

Chapter: 6 INTRAOCULAR LENS MARKET,  BY MATERIAL

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. POLYMETHYL METHACRYLATE (PMMA)

6.2.1. Market size and forecast

6.3. SILICONE

6.3.1. Market size and forecast

6.4. HYDROPHOBIC ACRYLIC

6.4.1. Market size and forecast

Chapter: 7 INTRAOCULAR LENS MARKET,  BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Netherlands market size and forecast
7.3.10. Norway market size and forecast
7.3.11. Russia market size and forecast
7.3.12. Sweden market size and forecast
7.3.13. Switzerland market size and forecast
7.3.14. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Australia market size and forecast
7.4.8. South Korea market size and forecast
7.4.9. New Zealand market size and forecast
7.4.10. Taiwan market size and forecast
7.4.11. Thailand market size and forecast
7.4.12. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. Saudi Arabia market size and forecast
7.5.6. South Africa market size and forecast
7.5.7. Chile market size and forecast
7.5.8. Columbia market size and forecast
7.5.9. Egypt market size and forecast
7.5.10. Iran market size and forecast
7.5.11. Israel market size and forecast
7.5.12. Turkey market size and forecast
7.5.13. Venezuela market size and forecast
7.5.14. Rest of LAMEA market size and forecast

Chapter: 8 COMPANY PROFILES

8.1. ALCON (A NOVARTIS AG DIVISION)

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. CARL ZEISS MEDITEC AG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. EYEKON MEDICAL, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio

8.4. HUMANOPTICS AG.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments

8.5. HOYA CORPORATION

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. JOHNSON & JOHNSON

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. LENSTEC, INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments

8.8. RAYNER INTRAOCULAR LENSES LTD.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments

8.9. STAAR SURGICAL COMPANY

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 1. VISION IMPAIRMENT BY AGE, 2010
TABLE 2. INTRAOCULAR LENS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 3. MONOFOCAL INTRAOCULAR LENS MARKET, BY REGION, 2014–2022 ($MILLION)
TABLE 4. NORTH AMERICA MONOFOCAL INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 5. EUROPE MONOFOCAL INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 6. ASIA-PACIFIC MONOFOCAL INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 7. LAMEA MONOFOCAL INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 8. PREMIUM INTRAOCULAR LENS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 9. PREMIUM INTRAOCULAR LENS MARKET, BY REGION, 2014–2022 ($MILLION)
TABLE 10. NORTH AMERICA PREMIUM INTRAOCULAR LENS MARKET, BY COUNTRY,  2014–2022 ($MILLION)
TABLE 11. EUROPE PREMIUM INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 12. ASIA-PACIFIC PREMIUM INTRAOCULAR LENS MARKET, BY COUNTRY,  2014–2022 ($MILLION)
TABLE 13. LAMEA PREMIUM INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 14. OTHER INTRAOCULAR LENSES MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 15. GLOBAL INTRAOCULAR LENS MARKET, BY END USER, 2014–2022($MILLION)
TABLE 16. NORTH AMERICA INTRAOCULAR LENS MARKET, BY END USER, 2014–2022 ($MILLION)
TABLE 17. EUROPE INTRAOCULAR LENS MARKET, BY END USER, 2014–2022 ($MILLION)
TABLE 18. ASIA-PACIFIC INTRAOCULAR LENS MARKET, BY END USER, 2014–2022 ($MILLION)
TABLE 19. LAMEA INTRAOCULAR LENS MARKET, BY END USER, 2014–2022 ($MILLION)
TABLE 20. INTRAOCULAR LENS MARKET FOR HOSPITALS, BY REGION, 2014–2022 ($MILLION)
TABLE 21. INTRAOCULAR LENS MARKET FOR AMBULATORY SURGERY CENTERS,  BY REGION, 2014–2022 ($MILLION)
TABLE 22. INTRAOCULAR LENS MARKET FOR OPHTHALMOLOGY CLINICS, BY REGION, 2014–2022 ($MILLION)
TABLE 23. INTRAOCULAR LENS MARKET FOR EYE RESEARCH INSTITUTES, BY REGION, 2014–2022 ($MILLION)
TABLE 24. GLOBAL INTRAOCULAR LENS MARKET, BY MATERIAL, 2014–2022 ($MILLION)
TABLE 25. NORTH AMERICA INTRAOCULAR LENS MARKET, BY MATERIAL, 2014–2022 ($MILLION)
TABLE 26. EUROPE INTRAOCULAR LENS MARKET, BY MATERIAL, 2014–2022 ($MILLION)
TABLE 27. ASIA-PACIFIC INTRAOCULAR LENS MARKET, BY MATERIAL, 2014–2022 ($MILLION)
TABLE 28. LAMEA INTRAOCULAR LENS MARKET, BY MATERIAL, 2014–2022 ($MILLION)
TABLE 29. INTRAOCULAR LENS MARKET FOR POLYMETHYL METHACRYLATE, BY REGION, 2014–2022 ($MILLION)
TABLE 30. GLOBAL INTRAOCULAR LENS MARKET FOR SILICONE, BY REGION, 2014–2022 ($MILLION)
TABLE 31. INTRAOCULAR LENS MARKET FOR HYDROPHOBIC ACRYLIC, BY REGION,  2014–2022 ($MILLION)
TABLE 32. INTRAOCULAR LENS MARKET, BY REGION, 2014–2022 ($MILLION)
TABLE 33. INTRAOCULAR LENS MARKET, BY REGION, 2014–2022 (UNITS)
TABLE 34. NORTH AMERICA INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 35. NORTH AMERICA INTRAOCULAR LENS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 36. NORTH AMERICA INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 (UNITS)
TABLE 37. EUROPE INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 38. EUROPE INTRAOCULAR LENS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 39. EUROPE INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 (UNITS)
TABLE 40. ASIA-PACIFIC INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 41. ASIA-PACIFIC INTRAOCULAR LENS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 42. ASIA-PACIFIC INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 (UNITS)
TABLE 43. LAMEA INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 44. LAMEA INTRAOCULAR LENS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 45. LAMEA INTRAOCULAR LENS MARKET, BY COUNTRY, 2014–2022 (UNITS)
TABLE 46. NOVARTIS: COMPANY SNAPSHOT
TABLE 47. NOVARTIS: OPERATING SEGMENTS
TABLE 48. NOVARTIS: PRODUCT PORTFOLIO
TABLE 49. CARL ZEISS: COMPANY SNAPSHOT
TABLE 50. CARL ZEISS: OPERATING SEGMENTS
TABLE 51. CARL ZEISS: PRODUCT PORTFOLIO
TABLE 52. EYEKON: COMPANY SNAPSHOT
TABLE 53. EYEKON: OPERATING SEGMENTS
TABLE 54. EYEKON: PRODUCT PORTFOLIO
TABLE 55. HUMANOPTICS: COMPANY SNAPSHOT
TABLE 56. HUMANOPTICS: OPERATING SEGMENTS
TABLE 57. HUMANOPTICS: PRODUCT PORTFOLIO
TABLE 58. HOYA: COMPANY SNAPSHOT
TABLE 59. HOYA: OPERATING SEGMENTS
TABLE 60. HOYA: PRODUCT PORTFOLIO
TABLE 61. J&J: COMPANY SNAPSHOT
TABLE 62. J&J: OPERATING SEGMENTS
TABLE 63. J&J: PRODUCT PORTFOLIO
TABLE 64. LENSTEC: COMPANY SNAPSHOT
TABLE 65. LENSTEC: OPERATING SEGMENTS
TABLE 66. RAYNER: COMPANY SNAPSHOT
TABLE 67. RAYNER: OPERATING SEGMENTS
TABLE 68. RAYNER: PRODUCT PORTFOLIO
TABLE 69. STAAR: COMPANY SNAPSHOT
TABLE 70. STAAR: OPERATING SEGMENTS
TABLE 71. STAAR: PRODUCT PORTFOLIO
TABLE 72. VALEANT: COMPANY SNAPSHOT
TABLE 73. VALEANT: OPERATING SEGMENTS
TABLE 74. BAUSCH+LOMB: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. INTRAOCULAR LENS MARKET, BY TYPE, 2015 VS 2022 ($MILLION)
FIGURE 2. MARKET SEGMENTATION
FIGURE 3. TOP WINNING STRATEGIES, 2014–2016 (%)
FIGURE 4. TOP WINNING STRATEGIES, ORGANIC AND INORGANIC
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DEVELOPMENT STRATEGIES ADOPTED BY COMPANIES(COMPANY AND NATURE OF STRATEGY)
FIGURE 7. DEVELOPMENT STRATEGIES ADOPTED BY COMPANIES (COMPANY AND TYPE OF STRATEGY)
FIGURE 8. TOP INVESTMENT POCKETS
FIGURE 9. MARKET SHARE ANALYSIS, 2015
FIGURE 10. MAJOR CAUSES OF VISUAL IMPAIRMENT WORLDWIDE, 2010
FIGURE 11. MAJOR CAUSES OF BLINDNESS WORLDWIDE, 2010
FIGURE 12. IMPAIRMENT BY WHO REGION AND COUNTRY, 2010
FIGURE 13. IMPACT ANALYSIS
FIGURE 14. HIGH BARGAINING POWER OF BUYERS, 2015
FIGURE 15. LOW BARGAINING POWER OF SUPPLIERS, 2015
FIGURE 16. LOW THREAT OF SUBSTITUTES, 2015
FIGURE 17. LOW THREAT OF NEW ENTRANTS, 2015
FIGURE 18. HIGH COMPETITIVE RIVALRY, 2015
FIGURE 19. GEOGRAPHICAL DISTRIBUTION OF IOL CLINICAL TRIALS
FIGURE 20. IOL CLINICAL TRIALS, BY COUNTRY
FIGURE 21. IOL CLINICAL TRIALS, BY PHASE
FIGURE 22. TORIC INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 23. MULTIFOCAL INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 24. ACCOMMODATING INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 25. BLUE-LIGHT FILTERING INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 26. PHAKIC INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 27. ASPHERIC INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 28. U.S. INTRAOCULAR LENS MARKET, 2014–2022($MILLION)
FIGURE 29. CANADA INTRAOCULAR LENS MARKET, 2014–2022($MILLION)
FIGURE 30. MEXICO INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 31. CATARACT SURGERY PROCEDURES PERFORMED IN EUROPE,  BY DEMOGRAPHICS, 2012
FIGURE 32. GERMANY INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 33. FRANCE INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 34. UK INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 35. ITALY INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 36. SPAIN INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 37. NETHERLANDS INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 38. NORWAY INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 39. RUSSIA INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 40. SWEDEN INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 41. SWITZERLAND INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 42. REST OF EUROPE INTRAOCULAR LENS MARKET, 2014–2022 ($MILLION)
FIGURE 43. LEADING CAUSES OF BLINDNESS IN JAPAN, 2013
FIGURE 44. LEADING CAUSES OF BLINDNESS IN INDIA, 2014
FIGURE 45. JAPAN INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 46. CHINA INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 47. INDIA INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 48. AUSTRALIA INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 49. SOUTH KOREA INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 50. NEW ZEALAND INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 51. TAIWAN INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 52. THAILAND INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 53. REST OF ASIA-PACIFIC INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 54. BRAZIL INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 55. SAUDI ARABIA INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 56. SOUTH AFRICA INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 57. CHILE INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 58. COLUMBIA INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 59. EGYPT INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 60. IRAN INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 61. ISRAEL INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 62. TURKEY INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 63. VENEZUELA INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 64. REST OF LAMEA INTRAOCULAR LENS MARKET, 2014-2022 ($MILLION)
FIGURE 65. NOVARTIS: NET SALES, 2014-2016 ($MILLION)
FIGURE 66. NOVARTIS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 67. NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 68. CARL ZEISS: NET SALES, 2014-2016 ($MILLION)
FIGURE 69. CARL ZEISS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 70. CARL ZEISS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 71. HOYA: NET SALES, 2014-2016 ($MILLION)
FIGURE 72. HOYA: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 73. HOYA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 74. J&J: NET SALES, 2014–2016 ($MILLION)
FIGURE 75. J&J: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 76. J&J: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 77. STAAR: NET SALES, 2014–2016 ($MILLION)
FIGURE 78. STAAR: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 79. VALEANT: NET SALES, 2014-2016 ($MILLION)
FIGURE 80. VALEANT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 81. VALEANT: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

 

Ophthalmic diseases such as cataract constitute a major proportion of health and economic burden; hence, the development of effective treatment options is a vital need for the elimination of blindness. Intraocular lens (IOLs) is an implantable device that is used to replace the natural lens of the eyes during cataract surgery.

Increase in incidence of cataract has led to high adoption of different types of IOLs such as monofocal and premium IOLs, owing to their various benefits such as enhanced visual performance. Moreover, rise in geriatric population susceptible to ophthalmic disease and increase in awareness initiatives to eliminate avoidable blindness have supplemented the growth of the market.

However, unfavorable reimbursement scenario for premium IOL restricts the market growth. Premium IOLs have additional features as compared to monofocal lens and thus cost more than conventional IOLs. Health insurance companies do not consider these features as a medical necessity and hence do not cover the cost of surgery, which in turn impedes the market growth.

Asia-Pacific offers lucrative growth opportunity for the market due to increase in healthcare expenditure, growth in geriatric population, and rise in incidence of cataract. Thus, emerging economies such as China and India possess high market potential.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Intraocular Lens Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $4176 $3759
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640 $4176
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540 $4709
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654 $5324
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9280 $6960
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo